Form 8-K DEPOMED INC For: May 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St set to fall at open as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Caribou Biosciences to halt CAR-T programs, explore sale
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
DepoMed (DEPO) Misses Q1 EPS by 14c; Guides FY15 Sales Above Views
May 11, 2015 4:15 PM EDTDepoMed (NASDAQ: DEPO) reported Q1 EPS of ($0.13), $0.14 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $31.7 million versus the consensus estimate of $33.8 million.
DepoMed sees FY2015 revenue of $310-335 million, versus the consensus of $305.02 million.
For earnings history and earnings-related data on DepoMed (DEPO) click here.
... More


